Resultados de procura - Liuqing Zheng

Case report: Durable response of ensartinib targeting EML4-ALK fusion in osimertinib-resistant non-small cell lung cancer por Yongkuan Guo, Ran Zhang, Yiran Meng, Li Wang, Liuqing Zheng, Jian You

Connect to this object online.

Case report: Favorable efficacy of combined afatinib and anlotinib treatment in a lung adenocarcinoma patient harboring uncommon EGFR L858M/L861R mutations por Yueming He, Yitao Wu, Rongqi He, Meng Xu, Heshan Chen, Yiran Meng, Liuqing Zheng, Li Wang

Connect to this object online.